At a glance
ClinicalIndex Comparison RecordN/ACompleted
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Genetic Analysis of Familial Hypertrophic Cardiomyopathy
National Heart, Lung, and Blood Institute (NHLBI)·observational·Posted May 26, 2000·Updated Mar 16, 2016
In Brief
An observational study for Cardiovascular Diseases and 3 related conditions. Completed.
Detailed Summary
To map the genetic defect responsible for familial hypertrophic cardiomyopathy.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases, Heart Diseases, Myocardial Diseases, Cardiomyopathy, Hypertrophic
Countries--
Collaborators--
Timeline
N/ACompletedFinished
198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJan 1990
Study CompletionMar 1995
First PostedMay 2000
TodayJul 2026
First PostedMay 26, 2000
Enrollment StartJan 1, 1990
Study CompletionMar 1, 1995
TodayJul 2, 2026
Posted 26.1 years ago